CK Hutchison Holdings Ltd/ KYG217651051 /
9/29/2023 10:08:20 AM | Chg. +1.15 | Volume | Bid10:08:20 AM | Ask10:08:20 AM | High | Low |
---|---|---|---|---|---|---|
41.90HKD | +2.82% | 5.15 mill. Turnover: 209.2 mill. |
41.85Bid Size: 127,000 | 41.90Ask Size: 265,000 | 42.10 | 40.70 |
GlobeNewswire
8/6/2021
Three UK Expands Strategic Collaboration with Amdocs to Provide Consumers with Next-Generation Digit...
GlobeNewswire
7/23/2021
Stabilizing Actions and End of Stabilization Period in connection with the Global Offering
GlobeNewswire
7/12/2021
HUTCHMED Announces Full Exercise of the Over-allotment Option of the Global Offering
GlobeNewswire
6/30/2021
HUTCHMED Announces the Closing of the Global Offering and the Primary Listing in Hong Kong
GlobeNewswire
5/18/2021
Viper Networks and Local Partner Interconnected with Airtel, Hutch and SLT to Launch 100 Million Pha...
GlobeNewswire
9/29/2020
Three UK Migrates Evolving Systems’ Total Number Management (TNM™) to Microsoft Azure in OSS/BSS Tra...
GlobeNewswire
6/30/2020
Amdocs Chosen by Three to Support its Enterprise Business in the UK in Multi-Year Deal
GlobeNewswire
3/3/2020
Hutchison Drei Austria Selects Metaswitch MaX UC Platform for Business Service Expansion
Newsfile Corp
2/12/2020
Queen's Road Capital Announces Private Placement & Appointment of Mr. Don Roberts
GlobeNewswire
11/12/2019
Amdocs Supports Three Ireland’s Successful Business-Led Transformation for Enhanced Customer and Emp...
GlobeNewswire
10/31/2019
Tru Niagen® Wins ‘Most Favourite Brand’ Award Among Watsons Hong Kong Loyalty Members
GlobeNewswire
9/30/2019
CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its inte...
GlobeNewswire
9/30/2019
CK Hutchison offers 1.3% of Chi-Med’s share capital aiming to deconsolidate and hold Chi-Med as a st...
GlobeNewswire
8/22/2019
Hutchison Drei Austria Launches Network-based Security Solution, Powered by Allot, to Protect Mobile...
GlobeNewswire
7/30/2019
Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs
GlobeNewswire
6/28/2019
Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares
GlobeNewswire
6/14/2019
Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim ...
GlobeNewswire
4/15/2019
Chi-Med Files Application to List in Hong Kong and Announces Proposed Global Offering